Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Nasal Spray for Post-COVID-19 Anosmia
NCT04484493Phase 3Completed
- Sponsor
- Benha University
- Start
- Aug 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone furoate nasal spray in anosmia, sponsored by Benha University. Started Aug 2020; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
anosmia
Beyond the preview
Go deeper on NCT04484493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04484493.